BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33577030)

  • 1. Long non-coding RNA DANCR promoted non-small cell lung cancer cells metastasis via modulating of miR-1225-3p/ErbB2 signal.
    Huang YF; Zhang Y; Fu X
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):758-769. PubMed ID: 33577030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
    Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
    Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
    Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of lncRNA DANCR functions as an oncogenic role in non-small lung cancer by regulating miR-214-5p/CIZ1 axis.
    Chen YR; Wu YS; Wang WS; Zhang JS; Wu QG
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2539-2547. PubMed ID: 32196604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA MIR155HG knockdown suppresses cell proliferation, migration and invasion in NSCLC by upregulating TP53INP1 directly targeted by miR-155-3p and miR-155-5p.
    Ren XY; Han YD; Lin Q
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4822-4835. PubMed ID: 32432745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NEAT1 regulated cell proliferation, invasion, migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer.
    Chen LM; Niu YD; Xiao M; Li XJ; Lin H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4810-4821. PubMed ID: 32432744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA-DANCR exerts oncogenic functions in non-small cell lung cancer via miR-758-3p.
    Wang S; Jiang M
    Biomed Pharmacother; 2018 Jul; 103():94-100. PubMed ID: 29635134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
    Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA differentiation antagonizing nonprotein coding RNA promotes the proliferation, invasion and migration of neuroblastoma cells via targeting β-1, 4-galactosyltransferase III by sponging miR-338-3p.
    Bi C; Shan J; Li M; Zhang Q; Li C; Tong J; Huang Q
    Neuroreport; 2021 Aug; 32(12):965-974. PubMed ID: 34050113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer.
    Li X; Zhu J; Liu Y; Duan C; Chang R; Zhang C
    Cancer Sci; 2019 Jun; 110(6):1883-1896. PubMed ID: 30955235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S; Wang K; Huang X; Zhao Z; Zhao Z
    Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
    Ge T; Wu HC; Zhou YY; Shen SM; Zhu LG; You GX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5823-5830. PubMed ID: 31298353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.